中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2012年
1期
129-131
,共3页
戴少军%杨少兵%刘成%李荣春%项红兵
戴少軍%楊少兵%劉成%李榮春%項紅兵
대소군%양소병%류성%리영춘%항홍병
色氨酸羟化酶%小干涉RNA%慢病毒%遗传载体
色氨痠羥化酶%小榦涉RNA%慢病毒%遺傳載體
색안산간화매%소간섭RNA%만병독%유전재체
Tryptophan hydroxylase%SiRNA%Lentivirus%Genetic vectors
目的 构建色氨酸羟化酶(TPH)-2基因小干涉RNA的重组慢病毒载体.方法 在TPH-2 mRNA序列中选择1个特异性靶序列,体外合成对应发卡样DNA片段,经退火后,将其定向克隆入siRNA载体,获得重组质粒pU6 -MCS-CMV-TPH2-shRNA,后者与慢病毒试剂共转染293细胞,同源重组产生Lentivirus-TPH2-siRNA.经聚合酶链反应(PCR)鉴定目的基因的表达并测定病毒滴度.结果 PCR表明Lentivirus-TPH2-siRNA构建正确,病毒滴度为3×108 TU/rnl.结论 获得的Lentivirus-TPH2-siRNA可以用于转基因瘙痒治疗的实验研究.
目的 構建色氨痠羥化酶(TPH)-2基因小榦涉RNA的重組慢病毒載體.方法 在TPH-2 mRNA序列中選擇1箇特異性靶序列,體外閤成對應髮卡樣DNA片段,經退火後,將其定嚮剋隆入siRNA載體,穫得重組質粒pU6 -MCS-CMV-TPH2-shRNA,後者與慢病毒試劑共轉染293細胞,同源重組產生Lentivirus-TPH2-siRNA.經聚閤酶鏈反應(PCR)鑒定目的基因的錶達併測定病毒滴度.結果 PCR錶明Lentivirus-TPH2-siRNA構建正確,病毒滴度為3×108 TU/rnl.結論 穫得的Lentivirus-TPH2-siRNA可以用于轉基因瘙癢治療的實驗研究.
목적 구건색안산간화매(TPH)-2기인소간섭RNA적중조만병독재체.방법 재TPH-2 mRNA서렬중선택1개특이성파서렬,체외합성대응발잡양DNA편단,경퇴화후,장기정향극륭입siRNA재체,획득중조질립pU6 -MCS-CMV-TPH2-shRNA,후자여만병독시제공전염293세포,동원중조산생Lentivirus-TPH2-siRNA.경취합매련반응(PCR)감정목적기인적표체병측정병독적도.결과 PCR표명Lentivirus-TPH2-siRNA구건정학,병독적도위3×108 TU/rnl.결론 획득적Lentivirus-TPH2-siRNA가이용우전기인소양치료적실험연구.
Objective To construct the recombinant lentivirus vector with tryptophan hydroxylase 2-siRNA (TPH 2-siRNA).Methods A target-specific sequence from TPH2 mRNA was used to synthesize the corresponding hairpin DNA fragments in vitro.After annealing,the DNA products were cloned into siRNA vector to obtain the recombinant siRNA vector plasmid pU6-MCS-CMV-TPH2-shRNA.The 293 cells were cotransfected by the Lentivirus vector and pU6-MCS-CMV-TPH2-shRNA,and the recombinant vector of Lentivirus-TPH2-siRNA was obtained.The expression of the transfected genes was evaluated by polymerase chain reaction (PCR) and the titer of purified virus was determined.Results The identification of PCR showed that the construction of the recombinant Lentivirus-TPH2-siRNA plasmid could be confirmed,and the titer of virus was 3 × 108 TU/ml after purified.Conclusion The Lentivirus-TPH2-siRNA vector can be used in empirical study of transgenic itch therapy.